Sponsor Pipeline

Shenzhen Kangzhe Biotechnology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07402369 Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia Uterine Fibroids With Menorrhagia Recruiting
Phase 1
NCT07462780 A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in… Paroxysmal Nocturnal Hemoglobinuria, PNH Recruiting
NCT07518589 Phase 1 Study of Ascending Doses of CMS-D008 in Healthy and Overweight/Obese Adults Evaluate the Safety and Tolerability Not Yet Recruiting
Disease Areas
Chronic Kidney Disease (1) Obesity (1)
Get alerts when Shenzhen Kangzhe Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free